Goldman Sachs’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
AA
LP
TCM
KIM
PAMP
AIMCA
LA
Goldman Sachs's TDAC Position: Q1 2026 in Review
Goldman Sachs held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 385,010 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3913.
Goldman Sachs first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- Goldman Sachs held 385,010 shares of Translational Development Acquisition Corp worth $4.07M as of Q1 2026.
- Goldman Sachs left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
- Translational Development Acquisition Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3913 holding.
- Goldman Sachs first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.